Lynch A Craig, Delaney Conor P, Senagore Anthony J, Connor Jason T, Remzi Feza H, Fazio Victor W
Department of Colorectal Surgery, Cleveland Clinic Foundation, Cleveland, OH 44195, USA.
Ann Surg. 2004 Nov;240(5):825-31. doi: 10.1097/01.sla.0000143895.17811.e3.
Recent experience with surgery for enterocutaneous fistulae (ECF) at a specialist colorectal unit is reviewed to define factors relating to a successful surgical outcome.
ECF cause significant morbidity and mortality and need experienced surgical management. Previous publications have concentrated on mortality resulting from fistulae, while factors affecting recurrence have not previously been a focus of analysis.
Records were reviewed of patients who had ECF surgery (1994-2001). Management strategy involved early drainage of sepsis and nutritional support prior to elective ECF repair, with selective defunctioning proximal stoma formation.
A total of 205 patients were available (89 males, 43%; median age, 51 years; range, 16-86) years). ECF were related to Crohn's disease in 95, ulcerative colitis in 18, diverticular disease in 17, carcinoma in 25 (16 after radiotherapy), mesh ventral hernia repair in 21, and other causes in 29. Forty-one (20%) had undergone attempted fistula repair at other institutions. Initial management included CT-guided drainage of an intra-abdominal abscess in 23 patients, and total parenteral nutrition in 74 (36%). A total of 203 patients had definitive ECF repair. Forty-four had oversewing or wedge resection of the fistula, and 159 had resection and reanastomosis of the involved small bowel segment or ileocolic anastomosis. Ninety-day operative mortality was 3.5%. A total of 42 (20.5%) patients developed ECF recurrence within 3 months. Multivariate analysis demonstrated that recurrence was more likely after oversewing (36%) than resection (16%, P = 0.006).
A strategy of drainage of acute sepsis, maintenance of nutritional support prior to surgery, and selective use of PS allows for primary closure in 80% of complicated ECF. Resection should be performed when feasible.
回顾一家专业结直肠病治疗中心近期肠皮肤瘘(ECF)手术的经验,以确定与手术成功结果相关的因素。
ECF会导致严重的发病率和死亡率,需要经验丰富的手术治疗。以往的出版物主要关注瘘导致的死亡率,而影响复发的因素此前并未成为分析的重点。
回顾了接受ECF手术(1994 - 2001年)患者的记录。管理策略包括在择期ECF修复术前早期引流脓毒症和提供营养支持,并选择性地形成近端造口以解除肠道功能。
共有205例患者(89例男性,占43%;中位年龄51岁;范围16 - 86岁)。95例ECF与克罗恩病有关,18例与溃疡性结肠炎有关,17例与憩室病有关,25例与癌症有关(16例为放疗后),21例与网状腹疝修补有关,29例由其他原因引起。41例(20%)曾在其他机构尝试过瘘修补术。初始治疗包括23例患者经CT引导下引流腹腔脓肿,74例(36%)患者接受全胃肠外营养。共有203例患者进行了确定性ECF修复。44例进行了瘘管缝合或楔形切除,159例进行了受累小肠段切除及吻合或回结肠吻合。90天手术死亡率为3.5%。共有42例(20.5%)患者在3个月内出现ECF复发。多因素分析表明,缝合术后复发的可能性(36%)高于切除术后(16%,P = 0.006)。
急性脓毒症引流、术前维持营养支持以及选择性使用近端造口的策略可使80%的复杂性ECF实现一期闭合。可行时应进行切除。